MASSACHUSETTS GENERAL HOSPITAL
Boosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles.
Boosting IL-12-induced anti-glioblastoma activity via immunotherapeutic extracellular vesicles. is a funding opportunity from MASSACHUSETTS GENERAL HOSPITAL, up to 160561, closing November 30, 2026.
Nov 30, 2026
(122d left)Overview
PROJECT SUMMARY The objective of this application is to develop the career of Dr. Breyne, facilitating his transition to a stable, independent phase and establishing his research program. He will pursue a rigorous career development plan to further his training in (i) extracellular vesicle (EV) biology, (ii)…